MINT-APREMILAST

Identification of Mint-Apremilast

No description

Google image searchProduct monograph

Active ingredient

apremilast, 30 MG

DIN: 02525747

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: MINT PHARMACEUTICALS INC

Date: 06-JAN-2023

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AA — Selective immunosuppressants (ATC, ATC/DDD)
• L04AA32 — APREMILAST (ATC/DDD)

External Links for Mint-Apremilast

Search on Google

• Mint-Apremilast side effects
• Mint-Apremilast dosage
• apremilast side effects
• apremilast dosage

Mint Pharmaceuticals Inc

Go to Mint website to see drug product details. Sometimes you can find mint-apremilast photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.